Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen

Autor: M. Jack Borrok, Chunning Yang, William Dall'acqua, Herren Wu, Yariv Mazor, Karen Aherne, Joanne Ayriss
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Physiology
Receptor
ErbB-2

Cytotoxicity
Antibody Affinity
lcsh:Medicine
Toxicology
Pathology and Laboratory Medicine
Biochemistry
Immunoglobulin G
White Blood Cells
Binding Analysis
0302 clinical medicine
Spectrum Analysis Techniques
Animal Cells
Genes
Reporter

Immune Physiology
Medicine and Health Sciences
Protein Isoforms
Receptor
lcsh:Science
Multidisciplinary
Immune System Proteins
biology
Effector
T Cells
Flow Cytometry
Antigenic Variation
Endocytosis
Cell biology
Antibody opsonization
ErbB Receptors
Spectrophotometry
030220 oncology & carcinogenesis
CD4 Antigens
Cytophotometry
Antibody
Cellular Types
Cell Binding Assay
Research Article
Cell Binding
Cell Physiology
Immune Cells
Immunology
Research and Analysis Methods
Antibodies
03 medical and health sciences
Immune system
Antigen
Cell Line
Tumor

Antigenic variation
Humans
Antigens
Chemical Characterization
Blood Cells
lcsh:R
Receptors
IgG

Antibody-Dependent Cell Cytotoxicity
Biology and Life Sciences
Proteins
Cell Biology
Molecular biology
030104 developmental biology
biology.protein
lcsh:Q
Zdroj: PLoS ONE
PLoS ONE, Vol 11, Iss 6, p e0157788 (2016)
ISSN: 1932-6203
Popis: Antibody-mediated immune effector functions play an essential role in the anti-tumor efficacy of many therapeutic mAbs. While much of the effort to improve effector potency has focused on augmenting the interaction between the antibody-Fc and activating Fc-receptors expressed on immune cells, the role of antibody binding interactions with the target antigen remains poorly understood. We show that antibody intrinsic affinity to the target antigen clearly influences the extent and efficiency of Fc-mediated effector mechanisms, and report the pivotal role of antibody binding valence on the ability to regulate effector functions. More particularly, we used an array of affinity modulated variants of three different mAbs, anti-CD4, anti-EGFR and anti-HER2 against a panel of target cell lines expressing disparate levels of the target antigen. We found that at saturating antibody concentrations, IgG variants with moderate intrinsic affinities, similar to those generated by the natural humoral immune response, promoted superior effector functions compared to higher affinity antibodies. We hypothesize that at saturating concentrations, effector function correlates most directly with the amount of Fc bound to the cell surface. Thus, high affinity antibodies exhibiting slow off-rates are more likely to interact bivalently with the target cell, occupying two antigen sites with a single Fc. In contrast, antibodies with faster off-rates are likely to dissociate each binding arm more rapidly, resulting in a higher likelihood of monovalent binding. Monovalent binding may in turn increase target cell opsonization and lead to improved recruitment of effector cells. This unpredicted relationship between target affinity and effector function potency suggests a careful examination of antibody design and engineering for the development of next-generation immunotherapeutics.
Databáze: OpenAIRE